文献速递眼底病与葡萄膜炎

干扰素α2a与全身皮质类固醇单药治疗慢性葡萄膜炎:随机对照BIRDFERON研究结果

Interferon-alpha2a and Systemic Corticosteroid in Monotherapy in Chronic Uveitis: Results of the Randomized Controlled BIRDFERON Study.
PubMed 文献 · Am J Ophthalmol · 2017-03-14

这项随机对照试验纳入48例双侧慢性非感染性后葡萄膜炎伴黄斑水肿的成人患者,比较皮下注射干扰素α2a、全身皮质类固醇与不治疗4个月的疗效与安全性。意向治疗分析中位黄斑中心凹厚度变化无显著差异,符合方案分析显示两治疗组较对照组有显著解剖学和视力改善。

要点

  • 符合方案分析中,对照组与皮质类固醇组右眼(OD)比较P=.0285,差异有统计学意义。
  • 符合方案分析中,对照组与干扰素α组右眼(OD)比较P=.0424,较差眼比较P=.0354,差异有统计学意义。
  • 意向治疗分析中,中位黄斑中心凹厚度变化在各组间无显著差异。

核心结论

  • 干扰素α与全身皮质类固醇相比不治疗,在符合方案分析中与显著的解剖学和视力改善相关。

研究设计与样本

  • 随机对照试验,纳入48例成人双侧后部自身免疫性非感染性非肿瘤性葡萄膜炎患者,至少1眼合并黄斑水肿。
  • 患者接受皮下注射干扰素α2a、全身皮质类固醇或不治疗,疗程4个月,疗效与安全性评估至4个月。

主要发现

  • 意向治疗分析中,中位黄斑中心凹厚度变化无显著差异。
  • 符合方案分析显示各组间双眼(右眼和左眼)以及较差眼和较好眼均有显著差异。
  • 符合方案分析中,对照组与皮质类固醇组右眼(OD)比较P=.0285。
  • 符合方案分析中,对照组与干扰素α组右眼(OD)比较P=.0424,较差眼比较P=.0354。
  • 严重不良事件:干扰素组2例,皮质类固醇组1例,对照组2例,均在转换治疗后完全缓解。

关键数值与推荐

  • 主要终点为光学相干断层扫描测得的黄斑中心凹厚度变化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Macular edema is the leading cause of vision loss in bilateral chronic noninfectious posterior uveitis, and is currently being treated using corticosteroids, immunosuppressive agents, and biotherapies. The aim of this trial was to assess and compare the efficacy and safety of corticosteroids and interferon-α (IFN-α) in adults with such conditions. DESIGN: Randomized controlled trial. METHODS: Subjects: Adult patients with bilateral posterior autoimmune noninfectious and nontumoral uveitis complicated by macular edema in at least 1 eye. INTERVENTION: Patients received either subcutaneous IFN-α2a, systemic corticosteroids, or no treatment for 4 months. The efficacy and safety were assessed for up to 4 months. MAIN OUTCOME MEASURES: The main endpoint was the change of the central foveal thickness (CFT) obtained by optical coherence tomography. RESULTS: Forty-eight patients were included. In intention-to-treat analysis, the median CFT change showed no significant difference. However, the per-protocol analysis showed a significant difference between groups for both eyes (OD and OS), and for the worse and better eyes. Statistically significant difference was found between the control and corticosteroid groups for the OD (P = .0285), and between the control and IFN-α groups for the OD (P = .0424) and worse eye (P = .0354). Serious adverse events occurred in 2 patients in the IFN group, in 1 patient in the corticosteroid group, and in 2 patients in the control group and were completely resolved after switch. CONCLUSIONS: IFN-α and systemic corticosteroids, compared with no treatment, were associated with significant anatomic and visual improvement shown in the per-protocol study.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Fardeau C, Simon A, Rodde B, et al. Interferon-alpha2a and Systemic Corticosteroid in Monotherapy in Chronic Uveitis: Results of the Randomized Controlled BIRDFERON Study. Am J Ophthalmol. 2017. PMID: 28315319. doi:10.1016/j.ajo.2017.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。